1. Home
  2. BOH vs IRON Comparison

BOH vs IRON Comparison

Compare BOH & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank of Hawaii Corporation

BOH

Bank of Hawaii Corporation

HOLD

Current Price

$78.90

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$64.97

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOH
IRON
Founded
1897
2017
Country
US
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BOH
IRON
Price
$78.90
$64.97
Analyst Decision
Hold
Strong Buy
Analyst Count
5
13
Target Price
$80.40
$101.92
AVG Volume (30 Days)
483.7K
817.9K
Earning Date
01-01-0001
04-14-2026
Dividend Yield
3.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.66
N/A
Revenue Next Year
$7.82
N/A
P/E Ratio
$17.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.45
$30.82
52 Week High
$80.61
$99.50

Technical Indicators

Market Signals
Indicator
BOH
IRON
Relative Strength Index (RSI) 64.30 38.81
Support Level $75.15 $40.00
Resistance Level $80.25 $73.97
Average True Range (ATR) 1.93 6.89
MACD 0.05 -1.47
Stochastic Oscillator 74.64 57.00

Price Performance

Historical Comparison
BOH
IRON

About BOH Bank of Hawaii Corporation

Bank of Hawaii Corp provides a broad range of financial products and services predominantly to customers in Hawaii, Guam, and other Pacific Islands. The Bank's subsidiaries are engaged in equipment leasing, securities brokerage, investment advisory services, and providing credit insurance. It is organized into three business segments for management reporting purposes: Consumer Banking, Commercial Banking, and Treasury and Other. Majority of the revenue is generated from Consumer Banking segment which offers a broad range of financial products and services, including loan, deposit and insurance products; private banking and international client banking services; trust services; investment management; and institutional investment advisory services.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: